dr. elizabeth plimack on nivolumab in kidney cancer
Published 8 years ago • 249 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:27
dr. elizabeth plimack on consideration regarding nivolumab in rcc
-
2:46
dr elizabeth plimack discusses prospective immunotherapy in kidney cancer management
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
2:48
dr elizabeth plimack discusses highlights from the 13th international kidney cancer symposium
-
4:43
nivolumab in renal cell carcinoma
-
0:49
dr. elizabeth plimack on immunotherapy potential in bladder cancer
-
6:52
nivolumab in renal cell carcinoma
-
4:35
metastatic renal cell carcinoma to the pancreas, ileum and liver; a case report emphasizing
-
2:35
papmet: met inhibitors in treating papillary renal cell carcinoma
-
8:43
immunotherapy in renal cell carcinoma
-
11:42
nivolumab in renal cell carcinoma
-
1:06
dr. plimack discusses recent trials in kidney cancer
-
1:09
dr. plimack on frontline pembrolizumab for urothelial carcinoma
-
1:18
dr. plimack on combo of pembrolizumab/epacodostat in bladder cancer
-
4:05
long-term rcc data with nivolumab
-
0:51
dr. elizabeth plimack on ipilimumab and pd-l1 inhibitors in the treatment of bladder cancer
-
0:47
dr. plimack on the challenges with available immunotherapies for bladder cancer
-
0:53
dr. plimack on strategies for developing cure for locally advanced urothelial carcinoma
-
1:04
dr. plimack on immunotherapy combinations in bladder cancer
-
6:44
immune checkpoint inhibition in renal cell carcinoma
-
2:26
elizabeth plimack, md, ms
-
1:18
dr. plimack on keynote-045 trial for pembrolizumab in urothelial carcinoma